Matches in SemOpenAlex for { <https://semopenalex.org/work/W2105064808> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2105064808 endingPage "458" @default.
- W2105064808 startingPage "457" @default.
- W2105064808 abstract "Following the 1994 Lancet paper showing benefits of long-acting β-agonists (LABAs) in adults with asthma,1 British Paediatric Respiratory Society surveys have consistently recommended undertaking similar studies appropriately designed for children. Adult outcome measures should not be extrapolated into childhood, which explains why early studies indicated LABAs may be less helpful in children.2 With the advent of the Medicines for Children Research Network (MCRN) in 2004, the Health Technology Assessment (HTA) put out a call for children's medicines studies in 2005. The Management of Asthma in School Children On Therapy (MASCOT) study was funded in January 2006 pending Pharma approval to supply the medicines (fluticasone, fluticasone–salmeterol combination treatment and montelukast) as National Institute for Health Research funding does not include excess treatment costs. This task took 12 months including lengthy discussions with Merck, Sharp and Dome (MSD) about methodology and statistics. The protocol required 900 children to use inhaled corticosteroids (ICS) for a 4 week open run-in followed by 48 weeks (double blind, double dummy) taking ICS, ICS plus LABA or ICS plus montelukast. The primary outcome measure was the exacerbation rate. The HTA funded MASCOT research costs. MSD and GlaxoSmithKline (GSK) agreed to supply medication. There was a delay in appointing a trial coordinator to oversee the 13 sites which had readily agreed to participate. The lengthy task of writing the protocol to EU standards (in addition to the original protocol designed for HTA application) was new and baffling to many of us, as was the preparation and submission of the Clinical Trials Authorisation." @default.
- W2105064808 created "2016-06-24" @default.
- W2105064808 creator A5046538942 @default.
- W2105064808 creator A5052175038 @default.
- W2105064808 creator A5072288229 @default.
- W2105064808 date "2011-03-11" @default.
- W2105064808 modified "2023-09-25" @default.
- W2105064808 title "Clinical trials and tribulations: the MASCOT study" @default.
- W2105064808 cites W2041632375 @default.
- W2105064808 cites W2098633046 @default.
- W2105064808 cites W2123309257 @default.
- W2105064808 cites W2139291708 @default.
- W2105064808 cites W2151675554 @default.
- W2105064808 doi "https://doi.org/10.1136/thx.2010.156885" @default.
- W2105064808 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21398371" @default.
- W2105064808 hasPublicationYear "2011" @default.
- W2105064808 type Work @default.
- W2105064808 sameAs 2105064808 @default.
- W2105064808 citedByCount "17" @default.
- W2105064808 countsByYear W21050648082012 @default.
- W2105064808 countsByYear W21050648082013 @default.
- W2105064808 countsByYear W21050648082014 @default.
- W2105064808 countsByYear W21050648082015 @default.
- W2105064808 countsByYear W21050648082016 @default.
- W2105064808 countsByYear W21050648082017 @default.
- W2105064808 countsByYear W21050648082018 @default.
- W2105064808 countsByYear W21050648082020 @default.
- W2105064808 countsByYear W21050648082021 @default.
- W2105064808 crossrefType "journal-article" @default.
- W2105064808 hasAuthorship W2105064808A5046538942 @default.
- W2105064808 hasAuthorship W2105064808A5052175038 @default.
- W2105064808 hasAuthorship W2105064808A5072288229 @default.
- W2105064808 hasBestOaLocation W21050648081 @default.
- W2105064808 hasConcept C126322002 @default.
- W2105064808 hasConcept C142724271 @default.
- W2105064808 hasConcept C187212893 @default.
- W2105064808 hasConcept C204787440 @default.
- W2105064808 hasConcept C2776042228 @default.
- W2105064808 hasConcept C2776322731 @default.
- W2105064808 hasConcept C2776719499 @default.
- W2105064808 hasConcept C2777014857 @default.
- W2105064808 hasConcept C2780385302 @default.
- W2105064808 hasConcept C2781212218 @default.
- W2105064808 hasConcept C2909082789 @default.
- W2105064808 hasConcept C512399662 @default.
- W2105064808 hasConcept C71924100 @default.
- W2105064808 hasConceptScore W2105064808C126322002 @default.
- W2105064808 hasConceptScore W2105064808C142724271 @default.
- W2105064808 hasConceptScore W2105064808C187212893 @default.
- W2105064808 hasConceptScore W2105064808C204787440 @default.
- W2105064808 hasConceptScore W2105064808C2776042228 @default.
- W2105064808 hasConceptScore W2105064808C2776322731 @default.
- W2105064808 hasConceptScore W2105064808C2776719499 @default.
- W2105064808 hasConceptScore W2105064808C2777014857 @default.
- W2105064808 hasConceptScore W2105064808C2780385302 @default.
- W2105064808 hasConceptScore W2105064808C2781212218 @default.
- W2105064808 hasConceptScore W2105064808C2909082789 @default.
- W2105064808 hasConceptScore W2105064808C512399662 @default.
- W2105064808 hasConceptScore W2105064808C71924100 @default.
- W2105064808 hasIssue "6" @default.
- W2105064808 hasLocation W21050648081 @default.
- W2105064808 hasLocation W21050648082 @default.
- W2105064808 hasLocation W21050648083 @default.
- W2105064808 hasLocation W21050648084 @default.
- W2105064808 hasOpenAccess W2105064808 @default.
- W2105064808 hasPrimaryLocation W21050648081 @default.
- W2105064808 hasRelatedWork W1971145825 @default.
- W2105064808 hasRelatedWork W199806695 @default.
- W2105064808 hasRelatedWork W2079098458 @default.
- W2105064808 hasRelatedWork W2099311124 @default.
- W2105064808 hasRelatedWork W2126856804 @default.
- W2105064808 hasRelatedWork W2129161565 @default.
- W2105064808 hasRelatedWork W2382700242 @default.
- W2105064808 hasRelatedWork W2386381627 @default.
- W2105064808 hasRelatedWork W2405439450 @default.
- W2105064808 hasRelatedWork W2182858306 @default.
- W2105064808 hasVolume "66" @default.
- W2105064808 isParatext "false" @default.
- W2105064808 isRetracted "false" @default.
- W2105064808 magId "2105064808" @default.
- W2105064808 workType "article" @default.